Here, the authors perform whole genome sequencing on 30 such tumours and identify recurrent mutations in IGLL5 and two activation induced cytidine deaminase signatures that are operative at different stages of CLL evolution. This evidence concerns the gene IGLL5 and B-cell chronic lymphocytic leukemia.